Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AMN

AMN Healthcare Announces $400 Million Note Offering

AMN Healthcare Services, Inc. (NYSE: AMN) has announced the launch of a $400.0 million offering of senior unsecured notes due 2031 by its wholly owned subsidiary, AMN Healthcare, Inc. The company plans to use the proceeds, along with cash on hand and borrowings under its secured revolving credit facility, to redeem all of its $500.0 million aggregate principal amount of 4.625% senior unsecured notes due 2027 outstanding and to pay fees and expenses related to the offering.

The 2031 notes will be guaranteed by the company’s affiliates that guarantee the company’s credit facilities. The company expects to deliver a conditional notice of redemption to holders of its outstanding 2027 notes, subject to the successful completion of the offering of the 2031 notes.

In 2024, AMN Healthcare's healthcare professionals reached nearly 15 million patients at more than 2,100 healthcare systems, including 87 percent of the top healthcare systems nationwide. The company provides a comprehensive network of quality healthcare professionals and delivers a fully integrated and customizable suite of workforce technologies. The market has reacted to these announcements by moving the company's shares -2.46% to a price of $18.66. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS